Paul Pelts
Psychiatry · New Orleans, LANPI 1477642676
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 290 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$734
- Tris Pharma Inc$635
- Otsuka America Pharmaceutical, Inc.$583
- Supernus Pharmaceuticals, Inc.$567
- Takeda Pharmaceuticals U.S.A., Inc.$508
- Sunovion Pharmaceuticals Inc.$457
- plus $3K from 17 others
What the payments were for
- Food & beverage$6,21199%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $734 |
| Tris Pharma Inc | 36 | $635 |
| Otsuka America Pharmaceutical, Inc. | 26 | $583 |
| Supernus Pharmaceuticals, Inc. | 15 | $567 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $508 |
| Sunovion Pharmaceuticals Inc. | 17 | $457 |
| Corium, LLC | 19 | $448 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $353 |
| Johnson & Johnson | 17 | $328 |
| Noven Therapeutics, LLC | 18 | $310 |
| Lundbeck LLC | 12 | $254 |
| Axsome Therapeutics, Inc. | 10 | $213 |
| Neos Therapeutics, LP | 11 | $189 |
| Ironshore Pharmaceuticals Inc. | 9 | $169 |
| Shire North American Group Inc | 7 | $141 |
| Rhodes Pharmaceuticals L.p. | 6 | $116 |
| Adlon Therapeutics L.p. | 6 | $92 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $28 |
| Noven Pharmaceuticals, Inc. | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,249 in reported general payments places this provider in the 90th percentile of 474 psychiatry providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuvelityDextromethorphan Hbr/Bupropion | 14 | $18,980 |
| TrintellixVortioxetine Hydrobromide | 20 | $9,129 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $658 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 20 | $387 |
| Lamotrigine | 35 | $362 |
| Zolpidem Tartrate | 22 | $215 |
| Bupropion XlBupropion Hcl | 29 | $215 |
| Escitalopram Oxalate | 28 | $212 |
| Paroxetine Hcl | 19 | $198 |
| Trazodone Hcl | 27 | $198 |
| Lurasidone Hcl | 12 | $149 |
| Sertraline Hcl | 24 | $146 |
| Aripiprazole | 21 | $146 |
| Risperidone | 37 | $131 |
| Clonazepam | 18 | $82 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $213 | $18,98014 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $508 | $9,12920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 474 psychiatry providers in Louisiana.
Other psychiatry in New Orleans
- Arwen PodestaNew Orleans$466K
- Andrew MorsonNew Orleans$56K
- James BarbeeNew Orleans$28K
- Neha KansaraNew Orleans$13K
- Erich ConradNew Orleans$9K
- Rahn BaileyNew Orleans$8K
- Nick RamandiNew Orleans$8K
- Ashley WeissNew Orleans$8K
- Ravindra ReddyNew Orleans$7K
- Janet BradleyNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.